T
he innate immune system is the first line of defense to protect hosts from invading microbial pathogens and is mediated by phagocytes, including macrophages and dendritic cells (DCs). Pattern-recognition receptors (PRRs) recognize conserved molecular structures of microbes, which results in the triggering of innate immune responses. As representatives PRR, Toll-like receptors (TLRs) are characterized by a cytosolic effector Toll/interleukin-1 receptor (IL-1R) homology (TIR) domain and extracellular leucine-rich repeats (LRRs) that are responsible for the recognition of microbial molecules (1) . Among TLRs, TLR2, TLR4, and TLR5 sense bacterial lipopolysaccharide (LPS), lipoprotein, and flagellin on the cell surface, respectively, whereas viral nucleic acids are recognized by TLR3, TLR7/TLR8 (TLR7/8), and TLR9 on the endosomal membrane. Sensing by TLRs induces the activation of nuclear factor kappa B (NF-B), mitogen-activated protein kinases (MAPKs), and interferon regulatory factors (IRFs) via two major signaling pathways. These are the myeloid differentiation primary response gene 88 (MyD88)-dependent and TIR-domain-containing adapter-inducing interferon-␤ (TRIF)-dependent pathways, which result in the production of inflammatory mediators such as cytokines, nitric oxide (NO), or type ⌱ interferon (IFN) (1) .
Periodontitis is a chronic inflammatory disease of the supporting tissues around the teeth and is characterized by a large inflamed and necrotic area associated with a high bacterial burden and destruction of the alveolar bone. Gram-negative (G Ϫ ) bacteria such as Porphyromonas gingivalis (P. gingivalis), Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), and Fusobacterium nucleatum (F. nucleatum) are representative pathogens associated with periodontitis (2) (3) (4) . Although it has been reported that TLR2 and TLR4 play important roles in the host's innate immune response against periodontal pathogens, there is still controversy. Using a transfection assay, Kikkert et al. showed that sonicates of P. gingivalis and F. nucleatum induce IL-8 production in HEK 293 cells exclusively via a TLR2-dependent pathway, whereas both TLR2 and TLR4 are involved in A. actinomycetemcomitans-induced IL-8 production (5). However, in human periodontal ligament (HPDL) cells, P. gingivalis and F. nucleatum in-creased the gene expression of TLR2 and TLR4, and treatment with anti-TLR2 and anti-TLR4 antibodies reduced F. nucleatuminduced production of cytokines (6) , suggesting that both TLR2 and TLR4 may regulate the immune response induced by periodontal pathogens. In addition, endosomal TLRs such TLR9 are involved in the host defense against pathogenic bacteria. TLR9 deficiency led to decreased production of tumor necrosis factor alpha (TNF-␣) in group B Streptococcus (GBS)-infected macrophages (7) . Although it is known that F. nucleatum infection elicits TLR9 activation in monocytes (8) , the role of endosomal TLRs in the immune response of macrophages against periodontal bacteria has yet to be clearly elucidated. Therefore, in the present study, we sought to identify TLR signaling-mediated immune responses in macrophages against the periodontal pathogens F. nucleatum and A. actinomycetemcomitans.
MATERIALS AND METHODS
Mice. TLR2-, TLR4-and MyD88-deficient mice on a C57BL/6 background were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). Wild-type (WT) C57BL/6 mice were from Koatech (Pyeongtaek, South Korea). Mice with a combined deficiency of TLR2 and TLR4 were generated by interbreeding TLR2-and TLR4-deficient animals in our animal facility. Animal studies were approved by and followed the regulations of the Institutional Animal Care and Use Committee at Konyang University.
Bacterial culture. F. nucleatum (ATCC 25586) and A. actinomycetemcomitans (ATCC 43718) were purchased from the American Type Culture Collection (Manassas, VA, USA). Stock broths were inoculated into 10 ml of brain heart infusion (BHI) broth with hemin (5 mg/ml) and vitamin K (10 mg/ml) under anaerobic conditions at 37°C in an incubator. A 1/10 dilution of the overnight culture was prepared and allowed to grow with shaking to an optical density (at a wavelength of 600 nm) of 0.6, which corresponds to ϳ109 CFU/ml of viable bacteria by serial dilution and plate counts. After two washes with phosphate-buffered saline (PBS; pH 7.4), bacteria were diluted to the desired concentration with PBS or medium and used in subsequent experiments.
Preparation and stimulation of murine macrophages. Bone marrow-derived macrophages (BMDMs) were prepared as previously described (9) . Briefly, bone marrow from femur and tibia was extracted and dispersed in complete Iscove's modified Dulbecco's medium (IMDM) including 30% L929 cell culture supernatant, 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, MEM NEAA (Gibco MEM nonessential amino acids; Life Technologies, Carlsbad, CA, USA), and 1% penicillinstreptomycin. Bone marrow cells were cultured in 20 ml of complete IMDM in a 150-mm culture dish in a 5% CO 2 incubator at 37°C. At day 3, 10 ml of fresh medium was added, and the cells were incubated for an additional 3 days. The cells were washed twice in PBS and finally seeded in 48-well plates in triplicates at a concentration of 2 ϫ 10 5 cells/well. The day after plating, cells were infected with F. nucleatum and A. actinomycetemcomitans at different multiplicities of infection (MOIs), presented as macrophage/bacterium ratios. Culture supernatants were collected at the times indicated in the figure legends after infection for further analysis.
Measurement of cytokines. The concentrations of IL-6, TNF-␣, and IL-12p40 in culture supernatants were determined using a commercial enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA).
Bacterial DNA isolation and reagents. Bacterial genomic DNA from F. nucleatum and A. actinomycetemcomitans was isolated using a G-spin Genomic DNA Extraction Kit (Intron, Seongnam, South Korea) according to the manufacturer's instructions. The concentration of DNA was measured using a spectrophotometer (Optizen 3220UV; Mecasys, Daejeon, South Korea) to determine 10 g/ml of bacterial DNA, which was used in the experiment to stimulate cytokine production by macrophages. Chloroquine diphosphate salt (10 and 50 nM; Sigma-Aldrich, St. Louis, MO, USA) and polymyxin B sulfate salt (50 g/ml; Sigma-Aldrich) were used for inhibition of endosomal TLRs and a lipopolysaccharide (LPS) response, respectively.
Immunoblotting. The cells were lysed in buffer containing 1% Nonidet-P40 supplemented with complete protease inhibitor cocktail (Roche, Mannheim, Germany) and 2 mM dithiothreitol. Lysates were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes by electroblotting. Membranes were immunoblotted with the following primary antibodies (regular and phosphorylated forms): IB␣, p38, extracellular signal-regulated kinase (ERK), and Jun N-terminal protein kinase (JNK) (Cell Signaling Technology, Beverly, MA, USA). After samples were subjected to immunoblotting with secondary antibodies, proteins were detected with enhanced chemiluminescence (ECL) reagent (Intron Biotechnology, Seongnam, South Korea).
Inhibitor assay. PD98059 (ERK inhibitor), SB203580 (p38 inhibitor), and SP600125 (JNK inhibitor) were purchased from Calbiochem (La Jolla, CA, USA). Bay 11-7082 (NF-B inhibitor) was purchased from Biomol (Plymouth Meeting, PA, USA). BMDMs were pretreated with various doses of each inhibitor 2 h before infection (10 to 40 M PD98059, SB203580, and Bay 11-7082 and 5 to 20 M SP600125). The cells were then infected with F. nucleatum and A. actinomycetemcomitans at an MOI of 1/10 in the absence or presence of each inhibitor. At 24 h after infection, culture supernatants were collected, and the concentrations of IL-6 and TNF-␣ were measured by ELISA.
Statistical analysis. The differences among the mean values of the different groups were assessed, and all data are expressed as the means Ϯ standard deviations (SD). All of the statistical calculations were performed by one-way analysis of variance (ANOVA), followed by a Bonferroni post hoc test for multigroup comparisons using GraphPad Prism, version 5.01 (GraphPad Software, San Diego, CA, USA). P values of Ͻ0.05 were considered statistically significant.
RESULTS

TLR2
and TLR4 are redundant in the cytokine production of macrophages in response to F. nucleatum and A. actinomycetemcomitans. To determine the involvement and redundancy of TLR2 and TLR4 in F. nucleatum-and A. actinomycetemcomitansinduced production of cytokines, BMDMs were infected with various doses of the bacteria for 6 or 18 h, and the levels of IL-6 and TNF-␣ were measured from the culture supernatant. The production of IL-6 and TNF-␣ in response to F. nucleatum and A. actinomycetemcomitans infection was partially impaired in TLR2-or TLR4-deficient macrophages, depending on the multiplicity of infection (MOI), compared to macrophages from WT mice ( Fig.  1A to D). Cytokine production by F. nucleatum and A. actinomycetemcomitans was much lower in TLR2 and TLR4 double-deficient (double knockout [DKO]) macrophages than in single TLR2-or TLR4-deficient cells (Fig. 1A to D) . At a late time of infection (18 h), IL-6 production was not impaired in TLR2-or TLR4-deficient macrophages infected with F. nucleatum at MOIs of 1/10 and 1/100 (Fig. 1E) . Even double deficiency of TLR2 and TLR4 did not affect F. nucleatum-induced IL-6 production in macrophages when cells were infected at an MOI of 1/100 (Fig.  1E) although A. actinomycetemcomitans-induced production of IL-6 was partially impaired (Fig. 1F) . TNF-␣ production showed a tendency similar to that with of IL-6 production by macrophages upon infection at an MOI of 1/100 with F. nucleatum and A. actinomycetemcomitans (data not shown).
MyD88 is essential for optimal production of cytokines in macrophages in response to F. nucleatum and A. actinomycetemcomitans. MyD88 is involved in the TLR2-and TLR4-mediated immune response. We explored the role of MyD88 in cytokine production by macrophages in response to F. nucleatum and A. actinomycetemcomitans infection. F. nucleatum-induced IL-6 production was mostly abolished in MyD88-deficient BMDMs ( Fig. 2A) . TNF-␣ and IL-12p40 production in response to F. nucleatum was also significantly lower in MyD88-deficient macrophages than in cells from WT mice (Fig. 2B and C) . A. actinomycetemcomitans-induced production of these cytokines was also much lower in MyD88-deficient macrophages than in WT cells (Fig. 2D to F) .
As shown in Fig. 1 , a high dose (MOI of 1/100) of F. nucleatum and A. actinomycetemcomitans can result in substantial production of IL-6 and TNF-␣ even in TLR2/4 double-deficient BMDMs, suggesting the involvement of other factors besides TLR2 and TLR4 in cytokine production by macrophages in response to periodontal pathogens. Because MyD88 is involved in multiple TLRmediated signaling pathways, including TLR5, TLR7, and TLR9 as well as TLR2 and TLR4, we sought to compare F. nucleatum-and A. actinomycetemcomitans-induced cytokine production levels in TLR2/4 double-deficient and MyD88-deficient macrophages infected at high dose (MOI of 1/100). As shown in Fig. 3A and B, F. nucleatum-induced production of IL-6 and TNF-␣ was significantly lower in MyD88-deficient macrophages than in macrophages from TLR2/4 DKO mice. Although the IL-6 levels could not be compared due to low production (Fig. 3C ), the TNF-␣ level induced by A. actinomycetemcomitans was significantly lower in MyD88-deficient macrophages than in TLR2/4 double-deficient cells (Fig. 3D) . These findings indicate that periodontal pathogens are able to lead to cytokine production in macrophages via a TLR2/4-independent but MyD88-dependent pathway.
Endosomal TLRs and bacterial DNA are involved in F. nucleatum-and A. actinomycetemcomitans-induced production of cytokines in TLR2/4 double-deficient macrophages. Chloroquine is known to suppress endosomal TLR activation by preventing endosomal acidification (10) . To determine whether endosomal TLRs mediate cytokine production in response to a high dose (MOI of 1/100) of periodontal bacteria, TLR2/4 double-deficient macrophages were infected with F. nucleatum and A. actinomycetemcomitans in the absence or presence of chloroquine. Chloroquine treatment (10 and 50 nM) reduced the production of IL-6 and TNF-␣ by F. nucleatum in TLR2/4 double-deficient macrophages ( Fig. 4A and B) . The production of IL-6 and TNF-␣ upon A. actinomycetemcomitans infection was also decreased by chloroquine in the cells (Fig. 4C and D ). An MTT [3-(4,5-dimethylthiazol-2-yl)2 2,5-diphenyl tetrazolium bromide] assay showed that chloroquine did not induce cytotoxicity at the doses used (data not shown). We next explored whether bacterial DNA from F. nucleatum and A. actinomycetemcomitans is involved in cytokine production in macrophages. DNA from F. nucleatum and A. actinomycetemcomitans produced substantial levels of IL-6 and TNF-␣ in macrophages, and this production was abolished by chloroquine ( Fig. 4E to H) . Treatment with polymyxin B did not BMDMs were infected with F. nucleatum or A. actinomycetemcomitans at the indicated MOI. At 6 (A to D) or 18 h (E and F) after infection, culture supernatants were collected, and IL-6 and TNF-␣ production was measured by ELISA. Data are shown as means Ϯ SD of triplicate samples from one experiment representative of three independent experiments performed (**, P Ͻ 0.01; ***, P Ͻ 0.001). A. a., A. actinomycetemcomitans. F. n., F. nucleatum; Uninf, uninfected; KO, knockout.
affect bacterial DNA-induced production of IL-6 and TNF-␣, thus ruling out LPS contamination (Fig. 4E to H) .
TLR2, TLR4, and MyD88 mediate the activation of NF-B and MAPKs in macrophages in response to F. nucleatum and A.
actinomycetemcomitans. In response to bacterial infection, TLRs induce the production of proinflammatory molecules through the NF-B transcription factor and MAPK signaling pathways (11, 12) . Western blot analysis was performed to determine whether TLR2, TLR4, and MyD88 mediate the activation of NF-B and MAPKs in macrophages induced by F. nucleatum and A. actinomycetemcomitans infection. Because a high dose of bacterial infection induced TLR2/TLR4-independent but MyD88-dependent cytokine production in macrophages ( Fig. 1 and 3 ), we infected macrophages at an MOI of 1/100 with F. nucleatum and A. actinomycetemcomitans. IB␣ degradation and phosphorylation induced by F. nucleatum and A. actinomycetemcomitans were delayed in TLR2/4 double-deficient macrophages and abolished in MyD88-deficient cells compared to WT macrophages ( Fig. 5A  and B) . F. nucleatum-induced phosphorylation of p38, JNK, and ERK was not impaired in TLR2/4 double-deficient macrophages but was delayed in MyD88-deficient cells (Fig. 5A) . The MAPK phosphorylation induced by A. actinomycetemcomitans was weaker in TLR2/4 double-deficient macrophages than in WT cells 30 min after infection, but levels were similar in both cell types at 60 min (Fig. 5B) . However, A. actinomycetemcomitans-induced MAPK phosphorylation was significantly impaired in MyD88-deficient cells (Fig. 5B) .
NF-B and MAPKs regulate the production of IL-6 and TNF-␣ in macrophages in response to F. nucleatum and A. actinomycetemcomitans. Finally, we performed an inhibitor assay to determine the involvement of NF-B and MAPKs in F. nucleatum-and A. actinomycetemcomitans-induced production of cytokines by macrophages. All inhibitors, including BAY 11-7802 (NF-B), SB203580 (p38), PD98059 (ERK), and SP600125 (JNK), reduced F. nucleatum-induced production of IL-6 and TNF-␣ by BMDMs in a dose-dependent manner ( Fig. 6A and B) . Interestingly, IL-6 and TNF-␣ production in response to A. actinomycetemcomitans was reduced by inhibition of NF-B and p38 but not by inhibition of ERK and JNK (Fig. 6C and D) . These findings suggest that NF-B and MAPKs may directly regulate cytokine production by macrophages in response to periodontal pathogens.
FIG 2 Cytokines production by WT and MyD88-deficient BMDMs in response to F. nucleatum and A. actinomycetemcomitans infection. BMDMs from WT and
MyD88-deficient mice were infected with F. nucleatum or A. actinomycetemcomitans for 6 h, and, as indicated, the levels of IL-6, TNF-␣, and IL-12p40 in the culture supernatant were measured by ELISA. Data are shown as means Ϯ SD of triplicate samples from one experiment representative of two independent experiments performed (**, P Ͻ 0.01; ***, P Ͻ 0.001). WT and TLR2/4-, and MyD88-deficient BMDMs were infected with F. nucleatum and A. actinomycetemcomitans for 6 h at an MOI of 1/100. IL-6 and TNF-␣ levels in the culture supernatant were measured by ELISA, as indicated. Data are shown as means Ϯ SD of triplicate samples from one experiment representative of three independent experiments performed (**, P Ͻ 0.01; ***, P Ͻ 0.001).
DISCUSSION
Although the function of TLRs in immune regulation has been studied in various cells in response to periodontal pathogens, the underlying mechanism is still unclear. There are inconsistent results among studies regarding the involvement of TLR2 and TLR4 in F. nucleatum-and A. actinomycetemcomitans-induced immune responses. Previous reports have shown that F. nucleatum-induced production of TNF-␣ and reactive oxygen species (ROS) was significantly lower in thioglycolate-elicited peritoneal macrophages from TLR2-deficient or TLR4-mutant (C3H/H3J) mice than from control WT cells (13, 14) . In human periodontal ligament (HPDL) cells, F. nucleatum-mediated production of cytokines and chemokines was reduced by treatment with TLR2 and TLR4 neutralizing antibodies (6) . In contrast, Kikkert et al. showed that F. nucleatum induces IL-8 production in HEK cells transfected with CD14-TLR2 but not in cells transfected with CD14-TLR4 (5). In addition, two studies revealed that both TLR2 and TLR4 mediate A. actinomycetemcomitans-induced production of cytokines and chemokines in HPDL or transfected HEK cells (5, 6) . On the other hand, in a study by Tietze et al., A. actinomycetemcomitans induced only TLR2 activity, and not TLR4, resulting in NF-B activation in transfected HEK cells (14) . These discrepancies seem to be due to different experimental conditions, such as the type of cells used, bacterial strains, and assay methods.
In the present study, the effect of TLR2 and TLR4 on F. nucleatum-and A. actinomycetemcomitans-induced production of cytokines in macrophages depended on bacterial dose and infection time. For example, F. nucleatum-induced IL-6 production at 6 h after infection was lower in TLR2-deficient macrophages than in WT cells when they were infected at an MOI of 1/10 but not at an MOI of 1/100. Moreover, there was a significant difference in IL-6 production induced by F. nucleatum between WT and TLR2-or TLR4-deficient macrophages at 6 h but not at 18 h after infection. Nevertheless, our study clearly revealed that both TLR2 and TLR4 are involved in the immune response of macrophages to F. nucleatum and A. actinomycetemcomitans.
Our results seem to indicate that TLR4 is critical for the immune responses to F. nucleatum and A. actinomycetemcomitans in macrophages. The structure of lipid A may be a major factor in TLR2/4-deficient BMDMs were pretreated with chloroquine (CLQ) 2 h before infection. The cells were then infected with F. nucleatum (A and B) and A. actinomycetemcomitans (C and D) for 6 h at an MOI of 1/100. WT BMDMs were treated with bacterial DNA from F. nucleatum (E and F) and A. actinomycetemcomitans (G and H) for 24 h in the absence or presence of chloroquine (50 nM) or polymyxin B (PMB; 50 g/ml). IL-6 and TNF-␣ levels in the culture supernatant were measured by ELISA. Data are shown as means Ϯ SD of triplicate samples from one experiment representative of two independent experiments performed (**, P Ͻ 0.01; ***, P Ͻ 0.001). (15, 16) . The recognition of lipid A by the immune system is indispensable for the onset of immune responses against G Ϫ bacterial infection. However, the immune-stimulating effect of lipid A is quite different, depending on bacterial species. Lipid IVa, an analogue of lipid A, acts as a stimulator of murine TLR4 but antagonizes the agonistic effect of lipid A on human TLR4 signaling (17) . Penta-acylated LPS from Pseudomonas aeruginosa is also an agonist of murine TLR4/MD-2, but it is an antagonist of human TLR4/MD-2 (18). In general, lipid A with a reduced number of acyl chains can serve as an inhibitor of immune activation induced by G Ϫ bacteria (19) . A previous study revealed that lipid A from F. nucleatum is a hexaacylated fatty acid composed of tetradecanoate (C 14 ) and hexadecanoate (C 16 ) and is structurally similar to Escherichia coli synthetic lipid A (20) . This may be an explanation for the strong TLR4 activity of F. nucleatum In contrast, the structure of P. gingivalis lipid A is different from that of E. coli. P. gingivalis lipid A exhibits remarkable structural heterogeneity and does not contain a sixth acyl chain (21) . In fact, LPS from P. gingivalis is less potent than that from E. coli (22) and induces different TLR activity (23) .
NF-B is a ubiquitous transcription factor and is involved in various inflammatory responses, including the production of cytokines (TNF-␣, IL-1␤, IL-6, and IL-8), chemokines, antimicrobial peptides (defensins), adhesion molecules (E-selectin, vascular cell adhesion molecule 1 [VCAM-1], and intercellular adhesion molecule 1 [ICAM-1]), inducible nitric oxide synthase (iNOS), and COX2 in host cells (24) . MAPKs also control a vast array of physiological processes such as cell proliferation and differentiation, regulation of transcription, and production of inflammatory cytokines (25) . In the present study, we revealed that the activation of NF-B and MAPKs by F. nucleatum and A. actinomycetemcomitans is regulated by a distinct signaling pathway. Although TLR2 and TLR4 were required for F. nucleatum-and A. actinomycetemcomitans-induced NF-B activation in macrophages, they were involved in MAPK activation only by A. actinomycetemcomitans and not by F. nucleatum. In addition, F. nucleatum-induced MAPK activation was delayed in MyD88-deficient macrophages, whereas their activation by A. actinomycetemcomitans was almost abolished. F. nucleatum and A. actinomycetemcomitans also seem to differently regulate cytokine production in macrophages. NF-B and all MAPKs were involved in cytokine production induced by F. nucleatum in BMDMs, whereas A. actinomycetemcomitans-induced production of cytokines was regulated by NF-B and p38 but not ERK and JNK. Cellular signaling elicited by F. nucleatum and A. actinomycetemcomitans seems to be differently regulated, depending on target molecules or host cell types. Ghosh et al. showed that all MAPK (p38, ERK, and JNK) inhibitors showed little or no effect on F. nucleatum cell wall-induced CCL20 secretion in human oral epithelial cells (26) . F. nucleatum induces collagenase 3 gene expression in human keratinocytes (HaCaT cells) via a p38-but not ERK-dependent pathway (27) . In addition, p38 and JNK, but not NF-B, mediate the induction of human ␤-defensin 2 (hBD-2) production in response to F. nucleatum in gingival epithelial cells (28) . Moreover, in contrast to our study, in previous work JNK was found to be involved in A. actinomycetemcomitans-mediated hBD-2 induction in oral epithelial cells (29) .
All TLRs, except TLR3, require MyD88 to signal downstream molecules. In the present study, cytokine production by F. nucleatum and A. actinomycetemcomitans was significantly lower in MyD88-deficient macrophages than in TLR2/4-deficient cells. Moreover, chloroquine reduced cytokine production in TLR2/4-deficient macrophages in response to both bacteria and DNA from F. nucleatum and A. actinomycetemcomitans, suggesting that endosomal TLRs, especially TLR9, may regulate F. nucleatum-and A. actinomycetemcomitans-induced immune responses in macrophages. Endosomal TLR9 can recognize certain types of bacterial DNA (unmethylated CpG DNA), which results in the production of proinflammatory mediators such as TNF-␣ and iNOS/NO by macrophages (30) . A previous study revealed that bacterial DNA from F. nucleatum can lead to TLR9 activation in monocytes (8) . In addition, BMDMs used in this study highly express the TLR9 gene compared with alveolar and peritoneal macrophages, and CpG oligodeoxynucleotide (ODN) induces the production of cytokines (IL-6, TNF-␣, and IL-12p40) in BMDMs (31) . Even though there is no evidence that A. actinomycetemcomitans induces TLR9 activity, it is likely that TLR9 participates in the immune response of macrophages in response to infection with periodontal pathogens such as F. nucleatum and A. actinomycetemcomitans.
In conclusion, our results show that multiple TLRs including TLR2, TLR4, and endosomal TLRs participate in immune responses of macrophages in response to periodontal pathogens such as F. nucleatum and A. actinomycetemcomitans. Because TNF-␣ was still produced in MyD88-deficient macrophages in response to F. nucleatum and A. actinomycetemcomitans, a further study is recommended to assess the role of other factors such as TRIF, a key molecule in MyD88-independent TLR signaling, and Nod-like receptors (e.g., Nod1 and Nod2) in mediating cytokine production in F. nucleatum-and A. actinomycetemcomitans-infected macrophages.
